Evidence map›Paper›PMID 36561723›Full record

ArticleFrontiers in medicine2022

Benjamin Lefèvre, Antoine Legoff, Mathilde Boutrou, François Goehringer, Willy Ngueyon-Sime, Catherine Chirouze, Matthieu Revest, Véronique Vernet Garnier, Xavier Duval, François Delahaye and 5 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03272724 recruitingnot on this map

French National Observatory on Infective Endocarditis

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan1991 to 2027Enrolled5,000ConditionsInfective Endocarditis
NCT03295045 completednot on this map

Evolution of the Profile of Infectious Endocarditis in France in 2008

TypeobservationalSponsorCentre Hospitalier Universitaire de BesanconRan2007 to 2010Enrolled484ConditionsInfective Endocarditis
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Benjamin LefèvreUniversité de Lorraine, CHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Nancy, France.
Antoine LegoffUniversité de Lorraine, CHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Nancy, France.
Mathilde BoutrouCH Andrée Rosemon, Unité de Maladies Infectieuses et Tropicales, Cayenne, France.
François GoehringerCHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Nancy, France.
Willy Ngueyon-SimeCHRU-Nancy, Institut National de la Sante et de la Recherche Medicale (INSERM), Université de Lorraine, CIC, Epidémiologie Clinique, Nancy, France.
Catherine ChirouzeUMR 6249 CNRS-UFC Chrono-environnement, Service de Maladies Infectieuses, CHRU Besançon, Besançon, France.
Matthieu RevestInfectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Véronique Vernet GarnierUFR Médecine, CHU Robert Debré, Reims, France.
Xavier DuvalInstitut National de la Sante et de la Recherche Medicale (INSERM) CIC 1425, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
François DelahayeLouis Pradel Hospital, Department of Cardiology, Lyon, France.
Vincent Le MoingMontpellier University Hospital, Department of Infectious and Tropical Diseases, Montpellier, France.
Christine Selton-SutyCHU Nancy-Brabois, Department of Cardiology, Nancy, France.
Laura FilippettiCHU Nancy-Brabois, Department of Cardiology, Nancy, France.
Bruno HoenUniversité de Lorraine, CHRU-Nancy, Service des Maladies Infectieuses et Tropicales, Nancy, France.
Nelly AgrinierUniversité de Lorraine, APEMAC, Nancy, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Lethality of Materials and methods: We used a two-step exploratory approach. First, using a qualitative approach derived from mortality and morbidity conferences, we conducted a review of the medical records of 30 patients with SaIE (15 deceased and 15 survivors), randomly extracted from an IE cohort database (NCT03295045), to detect new factors of possible prognostic interest. Second, we collected quantitative data for these factors in the entire set of SaIE patients and used multivariate Cox models to estimate their prognostic value. Results: A total of 134 patients with modified Duke definite SaIE were included, 64 of whom died during follow-up. Of the 56 candidate prognostic factors identified at the first step, 3 had a significant prognostic value in multivariate analysis: the prior use of non-steroidal anti-inflammatory drugs [aHR 3.60, 95% CI (1.59-8.15), Conclusion: We identified three potential SaIE prognostic factors. These results, if externally validated, might eventually help improve the management of patients with SaIE.

Indexed as

infective endocarditismorbidity and mortality conference methodprognostic factorsStaphylococcus aureussurvival

Identifiers

PMID36561723
PMCPMC9763316

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.